Ruxolitinib is a small molecule kinase inhibitor type pharmaceutical active ingredient that has found application in the treatment of certain hematological disorders. Some key areas where ruxolitinib API is utilized include: Myelofibrosis The main FDA approved application for ruxolitinib is in the treatment of myelofibrosis. Myelofibrosis is a rare bone marrow disorder that results in abnormal...